2007
DOI: 10.1159/000110016
|View full text |Cite
|
Sign up to set email alerts
|

Dihydropyrimidine Dehydrogenase Activity during Long-Term Adjuvant Treatment with Oral Uracil and Tegafur for Colorectal Cancer

Abstract: Background: Dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme for the degradation of 5-fluorouracil. The effect of long-term treatment with oral fluoropyrimidines on DPD activity has not been investigated. This study was conducted to examine changes in DPD activity in peripheral mononuclear cells (PMNC) during long-term treatment with oral uracil and tegafur (UFT) for colorectal cancer. Methods: UFT was administered for 5 consecutive days and not administered the next 2 days for 6 months after su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2011
2011

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…One advantage of oral treatment is patient convenience. Patients can take the medication themselves; there is no need for expensive hospitalization or the discomfort of injection, which is associated with a risk of extravasation or phlebitis [1][2][3] . However, cytotoxic drugs have a narrow therapeutic window; they must often be used at the highest tolerated dose due to their variable bioavailability, which may result in unanticipated toxicities or decreased efficacy when patients' plasma drug concentrations fail to achieve therapeutic levels.…”
Section: Introductionmentioning
confidence: 99%
“…One advantage of oral treatment is patient convenience. Patients can take the medication themselves; there is no need for expensive hospitalization or the discomfort of injection, which is associated with a risk of extravasation or phlebitis [1][2][3] . However, cytotoxic drugs have a narrow therapeutic window; they must often be used at the highest tolerated dose due to their variable bioavailability, which may result in unanticipated toxicities or decreased efficacy when patients' plasma drug concentrations fail to achieve therapeutic levels.…”
Section: Introductionmentioning
confidence: 99%
“…Several cytotoxic compounds having purine or pyrimidine bases in the molecule, such as azathiopurine 1, 5,6) 5-fluorouracil 2 (5-FU) 7-10) and tegafur 3, 11,12) have been synthesized and used in clinical chemotherapy. In this study, syntheses of anthraquinone derivatives having nucleic acid bases (adenine, thymine, uracil or 5-FU) on the side chain of the anthraquinone skeleton were performed (Fig.…”
Section: Chemical Results and Dicscussionmentioning
confidence: 99%